Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation

Venetoclax and donor lymphocyte infusion for early relapsed acute myeloid leukemia after allogeneic hematopoietic cell transplantation. A retrospective multicenter trial

(2021) Odelia Amit et al.   ANNALS OF HEMATOLOGY

NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021

(2021) Daniel A. Pollyea et al.   Journal of the National Comprehensive Cancer Network

Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndrome

(2021) Yunxiong Wei et al.   CANCER SCIENCE

RUNX1 mutation and elevated FLT3 gene expression cooperates to induce inferior prognosis in cytogenetically normal acute myeloid leukemia patients

(2021) Atia Rehman et al.   SAUDI JOURNAL OF BIOLOGICAL SCIENCES

Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1

(2021) Guadalupe Oñate et al.   Blood Advances

Acute myeloid leukemia transformed to a targetable disease

(2020) Khalil Saleh et al.   Future Oncology

Venetoclax is safe and efficacious in relapsed/refractory AML

(2020) Chezi Ganzel et al.   LEUKEMIA & LYMPHOMA

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

(2020) Courtney D. DiNardo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Current Therapeutic Results and Treatment Options for Older Patients with Relapsed Acute Myeloid Leukemia

(2019) Felicetto Ferrara et al.   Cancers

A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia

(2018) Bruno C. Medeiros et al.   Clinical Lymphoma Myeloma & Leukemia

Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

(2018) Ibrahim Aldoss et al.   HAEMATOLOGICA

Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

(2018) Ibrahim Aldoss et al.   HAEMATOLOGICA

Continuous high dosing of lenalidomide in relapsed, refractory or older newly diagnosed acute myeloid leukemia patients not suitable for other treatment options - results from a phase I study

(2018) Marie Luise Hütter-Krönke et al.   HAEMATOLOGICA

Venetoclax plus decitabine induced complete remission with molecular response in acute myeloid leukemia relapsed after hematopoietic stem cell transplantation

(2018) Giacomo Andreani et al.   AMERICAN JOURNAL OF HEMATOLOGY

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

(2018) Courtney D. DiNardo et al.   BLOOD

Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Non-randomized, Open-label, Phase 2 Study

(2018) Naval Daver et al.   Cancer Discovery

Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia

(2016) Lesley J. Scott   DRUGS

Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation

(2016) Armin Ghobadi et al.   LEUKEMIA RESEARCH

Genomic Classification and Prognosis in Acute Myeloid Leukemia

(2016) Elli Papaemmanuil et al.   NEW ENGLAND JOURNAL OF MEDICINE

Three-minute method for amino acid analysis by UHPLC and high-resolution quadrupole orbitrap mass spectrometry

(2015) Travis Nemkov et al.   AMINO ACIDS

5-Azacytidine and DLI can induce long-term remissions in AML patients relapsed after allograft

(2015) J Steinmann et al.   BONE MARROW TRANSPLANTATION

Management of Relapsed/Refractory Acute Myeloid Leukemia in the Elderly: Current Strategies and Developments

(2015) Jeffrey C. Bryan et al.   DRUGS & AGING

Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia

(2015) Steven M Chan et al.   NATURE MEDICINE

Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Second hematopoietic stem cell transplantation in myeloid malignancies

(2009) Lisa M Arfons et al.   CURRENT OPINION IN HEMATOLOGY